Side-by-side comparison of AI visibility scores, market position, and capabilities
Diversified industrial manufacturer with $15.9B FY2024 revenue; 80/20 business model drives 25%+ operating margins; 50+ year dividend growth streak; new CEO Chris O'Herlihy 2024.
Illinois Tool Works (ITW) is a diversified manufacturer of highly engineered industrial components, tools, and equipment, founded in 1912 in Chicago, Illinois where it remains headquartered, trading on NYSE (ITW). The company generated approximately $15.9 billion in revenues for FY2024 under CEO Christopher O'Herlihy, who succeeded longtime CEO E. Scott Santi in 2024 and continues the long-tenured management team's disciplined execution of ITW's 80/20 business model. ITW operates seven diversified segments: Automotive OEM (components for cars and trucks), Food Equipment (professional kitchen equipment and service), Test & Measurement and Electronics, Welding (Miller welders and equipment), Polymers & Fluids (adhesives, lubricants, sealants), Construction Products (anchors, fasteners, fire protection), and Specialty Products (diversified industrial niche products).
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.